Lactate Test Monitors Tissue Oxygenation

A new lactate test is designed for use in a critical care setting to detect, treat, and monitor decreased tissue oxygenation. The test has been cleared by the US Food and Drug Administration (FDA).

Decreased oxygenation is associated with shock, hypovolemia, and heart failure. Lactate testing is also used to monitor certain metabolic conditions. The new test is the product of Diametrics Medical, Inc. (St. Paul, MN. USA) and is to be used with the company's Irma blood gas analysis system. Irma is a portable analyzer that can perform a broad range of time-critical tests at the patient's bedside, including blood gases, electrolytes, chemistries, glucose, and hematocrit. Other products of Diametrics include a data-management system, a blood-gas monitoring system for use with adult, pediatric, and neonatal patients, and a cerebral tissue monitoring system.

"The addition of lactate testing to the Irma system will expand our ability to penetrate the global billion-dollar critical care blood analysis market, particularly in geographies outside the United States,” said David Giddings, president and CEO of Diametrics.




Related Links:
Diametrics